Chempass Company

ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.

Headquarters: Budapest, Budapest, Hungary
Funding Status: Seed
Employee Number: Undisclosed
Investment Stage: N/A
Number Of Exists: N/A
Technology: Drug Design
Investor Type: N/A
Founded Date: 2016
Industry: Drug Discovery